BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 14663047)

  • 1. Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study.
    Orland JR; Engstrom J; Fridey J; Sacher RA; Smith JW; Nass C; Garratty G; Newman B; Smith D; Wang B; Loughlin K; Murphy EL;
    Neurology; 2003 Dec; 61(11):1588-94. PubMed ID: 14663047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators.
    Murphy EL; Fridey J; Smith JW; Engstrom J; Sacher RA; Miller K; Gibble J; Stevens J; Thomson R; Hansma D; Kaplan J; Khabbaz R; Nemo G
    Neurology; 1997 Feb; 48(2):315-20. PubMed ID: 9040713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
    Romanelli LC; Caramelli P; Martins ML; Gonçalves DU; Proietti FA; Ribas JG; Araújo MG; Carneiro-Proietti AB
    AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1199-202. PubMed ID: 23617363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
    Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
    J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathy.
    Biswas HH; Engstrom JW; Kaidarova Z; Garratty G; Gibble JW; Newman BH; Smith JW; Ziman A; Fridey JL; Sacher RA; Murphy EL
    Neurology; 2009 Sep; 73(10):781-9. PubMed ID: 19738173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and epidemiological aspects of HTLV-II infection in São Paulo, Brazil: presence of tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM) simile diagnosis in HIV-1-co-infected subjects.
    Posada-Vergara MP; Montanheiro P; Fukumori LM; Bonasser F; Duarte AJ; Penalva de Oliveira AC; Casseb J
    Rev Inst Med Trop Sao Paulo; 2006; 48(4):207-10. PubMed ID: 17119676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I).
    Gessain A; Gout O
    Ann Intern Med; 1992 Dec; 117(11):933-46. PubMed ID: 1443956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica.
    Krämer A; Maloney EM; Morgan OS; Rodgers-Johnson P; Manns A; Murphy EL; Larsen S; Cranston B; Murphy J; Benichou J
    Am J Epidemiol; 1995 Dec; 142(11):1212-20. PubMed ID: 7485068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal trends in Human T-Lymphotropic virus 1 (HTLV-1) associated myelopathy/tropical spastic paraparesis (HAM/TSP) incidence in Martinique over 25 years (1986-2010).
    Olindo S; Jeannin S; Saint-Vil M; Signate A; Edimonana-Kaptue M; Joux J; Merle H; Richard P; Granjeaud S; Cabre P; Smadja D; Cesaire R; Lezin A
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006304. PubMed ID: 29554087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The current and future approaches to the treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
    Yamano Y; Sato T; Ando H; Araya N; Yagishita N
    Nihon Rinsho; 2012 Apr; 70(4):705-13. PubMed ID: 22568157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.
    Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S
    Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clustering of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and infective dermatitis associated with HTLV-1 (IDH) in Salvador, Bahia, Brazil.
    da Silva JL; Primo JR; de Oliveira Mde F; Batista Eda S; Moreno-Carvalho O; Farré L; Bittencourt AL
    J Clin Virol; 2013 Oct; 58(2):482-5. PubMed ID: 23932323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
    Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
    J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
    Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
    Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Peruvian family with a high burden of HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Alvarez C; Verdonck K; Tipismana M; Gotuzzo E
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26392440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HTLV-1 associated myelopathy: clinical and epidemiological profile in a 10-year case series study].
    Champs AP; Passos VM; Barreto SM; Vaz LS; Ribas JG
    Rev Soc Bras Med Trop; 2010; 43(6):668-72. PubMed ID: 21181020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load.
    Nose H; Saito M; Usuku K; Sabouri AH; Matsuzaki T; Kubota R; Eiraku N; Furukawa Y; Izumo S; Arimura K; Osame M
    J Neurovirol; 2006 Jun; 12(3):171-7. PubMed ID: 16877298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and demographic features of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Rio de Janeiro, Brazil.
    Araújo Ade Q; Alfonso CR; Schor D; Leite AC; de Andrada-Serpa MJ
    Acta Neurol Scand; 1993 Jul; 88(1):59-62. PubMed ID: 8372632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in northeast Iran.
    Shoeibi A; Rafatpanah H; Azarpazhooh A; Mokhber N; Hedayati-Moghaddam MR; Amiri A; Hashemi P; Foroghipour M; Hoseini RF; Bazarbachi A; Azarpazhooh MR
    Acta Neurol Belg; 2013 Dec; 113(4):427-33. PubMed ID: 23568138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.